A citation-based method for searching scientific literature

Koushik Muralidharan, Anudeep Yekula, Julia L Small, Zachary S Rosh, Keiko M Kang, Lan Wang, Spencer Lau, Hui Zhang, Hakho Lee, Chetan Bettegowda, Michael R Chicoine, Steven N Kalkanis, Ganesh M Shankar, Brian V Nahed, William T Curry, Pamela S Jones, Daniel P Cahill, Leonora Balaj, Bob S Carter. Clin Cancer Res 2021
Times Cited: 3







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.
Rakel Brendsdal Forthun, Randi Hovland, Cornelia Schuster, Hanne Puntervoll, Hans Petter Brodal, Heidi Maria Namløs, Lars Birger Aasheim, Leonardo A Meza-Zepeda, Bjørn Tore Gjertsen, Stian Knappskog,[...]. Sci Rep 2019
10
66

Understanding TERT Promoter Mutations: A Common Path to Immortality.
Robert J A Bell, H Tomas Rube, Ana Xavier-Magalhães, Bruno M Costa, Andrew Mancini, Jun S Song, Joseph F Costello. Mol Cancer Res 2016
114
66

Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples.
Broderick C Corless, Gregory A Chang, Samantha Cooper, Mahrukh M Syeda, Yongzhao Shao, Iman Osman, George Karlin-Neumann, David Polsky. J Mol Diagn 2019
22
66

Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR.
Anna L Reid, James B Freeman, Michael Millward, Melanie Ziman, Elin S Gray. Clin Biochem 2015
74
66

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number.
Benjamin J Hindson, Kevin D Ness, Donald A Masquelier, Phillip Belgrader, Nicholas J Heredia, Anthony J Makarewicz, Isaac J Bright, Michael Y Lucero, Amy L Hiddessen, Tina C Legler,[...]. Anal Chem 2011
66

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry.
Ana P Estrada-Flórez, Mabel E Bohórquez, Alejandro Vélez, Carlos S Duque, Jorge H Donado, Gilbert Mateus, Cesar Panqueba-Tarazona, Guadalupe Polanco-Echeverry, Ruta Sahasrabudhe, Magdalena Echeverry,[...]. Endocr Connect 2019
4
33

Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.
Iñigo Landa, Nikita Pozdeyev, Christopher Korch, Laura A Marlow, Robert C Smallridge, John A Copland, Ying C Henderson, Stephen Y Lai, Gary L Clayman, Naoyoshi Onoda,[...]. Clin Cancer Res 2019
35
33


Spatial Distribution Patterns of Clinically Relevant TERT Promoter Mutations in Follicular Thyroid Tumors of Uncertain Malignant Potential: Advantages of the Digital Droplet PCR Technique.
Martin Hysek, Kenbugul Jatta, L Samuel Hellgren, Adam Stenman, Catharina Larsson, Jan Zedenius, C Christofer Juhlin. J Mol Diagn 2021
3
33

Arms-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers With Worse Prognosis Determined by Coexisting BRAF V600E and Tert Promoter Mutations.
Peng-Cheng Yu, Li-Cheng Tan, Xiao-Li Zhu, Xiao Shi, Roman Chernikov, Arseny Semenov, Ling Zhang, Ben Ma, Yu Wang, Xiao-Yan Zhou,[...]. Endocr Pract 2021
2
50

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33


Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
33

Monitoring of urothelial cancer disease status after treatment by digital droplet PCR liquid biopsy assays.
John J G Pritchard, Graham Hamilton, Carolyn D Hurst, Sioban Fraser, Clare Orange, Margaret A Knowles, Robert J Jones, Hing Y Leung, Tomoko Iwata. Urol Oncol 2020
2
50

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
180
33

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.
Martyn Bullock, Yan Ren, Christine O'Neill, Anthony Gill, Adam Aniss, Mark Sywak, Stan Sidhu, Leigh Delbridge, Diana Learoyd, Florent de Vathaire,[...]. Clin Endocrinol (Oxf) 2016
36
33


Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
77
33

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
Mariana N L Oliveira, Jefferson P Hemerly, André U Bastos, Rosana Tamanaha, Flavia R M Latini, Cléber P Camacho, Anelise Impellizzeri, Rui M B Maciel, Janete M Cerutti. Thyroid 2011
20
33

twoddpcr: an R/Bioconductor package and Shiny app for Droplet Digital PCR analysis.
Anthony Chiu, Mahmood Ayub, Caroline Dive, Ged Brady, Crispin J Miller. Bioinformatics 2017
12
33

Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
Rong Bu, Abdul K Siraj, Sasidharan Padmaja Divya, Yan Kong, Sandeep Kumar Parvathareddy, Maha Al-Rasheed, Khadija A S Al-Obaisi, Ingrid G Victoria, Saif S Al-Sobhi, Mohammed Al-Dawish,[...]. Int J Cancer 2018
31
33


Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours.
Ana Pestana, Rui Batista, Ricardo Celestino, Sule Canberk, Manuel Sobrinho-Simões, Paula Soares. Cancers (Basel) 2020
4
33

Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer.
Tara Williamson, Thais Biude Mendes, Natalie Joe, Janete M Cerutti, Gregory J Riggins. Endocr Relat Cancer 2020
7
33

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
22
33

Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas.
Dorina Ylli, Aneeta Patel, Kirk Jensen, Zhao-Zhang Li, Maria Cecilia Mendonca-Torres, John Costello, Cristiane Jeyce Gomes-Lima, Leonard Wartofsky, Kenneth Dale Burman, Vasyl V Vasko. Cancers (Basel) 2019
7
33

Telomerase Reverse Transcriptase (TERT) Regulation in Thyroid Cancer: A Review.
Brittany A McKelvey, Christopher B Umbricht, Martha A Zeiger. Front Endocrinol (Lausanne) 2020
5
33

Using The Cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on Cancer staging for papillary thyroid carcinoma.
Anello Marcello Poma, Elisabetta Macerola, Liborio Torregrossa, Rossella Elisei, Ferruccio Santini, Fulvio Basolo. Endocrine 2021
2
50

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases.
Zhaowei Meng, Michiko Matsuse, Vladimir Saenko, Shunichi Yamashita, Peng Ren, Xiangqian Zheng, Qiang Jia, Jian Tan, Ning Li, Wei Zheng,[...]. IUBMB Life 2019
5
33

TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.
Xue Yang, Jiao Li, Xiaoyi Li, Zhiyong Liang, Wen Gao, Jun Liang, Shujun Cheng, Yansong Lin. J Nucl Med 2017
43
33

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
254
33

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
254
33

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
212
33

Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma.
Leslie Calapre, Tindaro Giardina, Cleo Robinson, Anna L Reid, Zeyad Al-Ogaili, Michelle R Pereira, Ashleigh C McEvoy, Lydia Warburton, Nicholas K Hayward, Muhammad A Khattak,[...]. Mol Oncol 2019
27
33

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Ricardo Leão, Joana Dias Apolónio, Donghyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo-Branco. J Biomed Sci 2018
74
33

Telomere Biology and Human Phenotype.
Kara J Turner, Vimal Vasu, Darren K Griffin. Cells 2019
68
33

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
357
33

Current and Emerging Applications of Droplet Digital PCR in Oncology.
Susana Olmedillas-López, Mariano García-Arranz, Damián García-Olmo. Mol Diagn Ther 2017
75
33

Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studies.
Ashleigh C McEvoy, Michelle R Pereira, Anna Reid, Robert Pearce, Lester Cowell, Zeyad Al-Ogaili, Muhammad A Khattak, Michael Millward, Tarek M Meniawy, Elin S Gray,[...]. Oncotarget 2019
10
33

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.
Marc Remke, Vijay Ramaswamy, John Peacock, David J H Shih, Christian Koelsche, Paul A Northcott, Nadia Hill, Florence M G Cavalli, Marcel Kool, Xin Wang,[...]. Acta Neuropathol 2013
99
33

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
178
33

Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer.
Md Ismail Hosen, Nathalie Forey, Geoffroy Durand, Catherine Voegele, Selin Bilici, Patrice Hodonou Avogbe, Tiffany Myriam Delhomme, Matthieu Foll, Arnaud Manel, Emmanuel Vian,[...]. Cancers (Basel) 2020
5
33

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.
Meena U Rajagopal, Yetrib Hathout, Tobey J MacDonald, Mark W Kieran, Sri Gururangan, Susan M Blaney, Peter Phillips, Roger Packer, Heather Gordish-Dressman, Brian R Rood. Proteomics 2011
37
33

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.
A A Ross, B W Cooper, H M Lazarus, W Mackay, T J Moss, N Ciobanu, M S Tallman, M J Kennedy, N E Davidson, D Sweet. Blood 1993
447
33

Application of exosomes as liquid biopsy in clinical diagnosis.
Biting Zhou, Kailun Xu, Xi Zheng, Ting Chen, Jian Wang, Yongmao Song, Yingkuan Shao, Shu Zheng. Signal Transduct Target Ther 2020
46
33

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
Sara R Bang-Christensen, Rasmus S Pedersen, Marina A Pereira, Thomas M Clausen, Caroline Løppke, Nicolai T Sand, Theresa D Ahrens, Amalie M Jørgensen, Yi Chieh Lim, Louise Goksøyr,[...]. Cells 2019
15
33

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy.
Huilin Shao, Jaehoon Chung, Leonora Balaj, Alain Charest, Darell D Bigner, Bob S Carter, Fred H Hochberg, Xandra O Breakefield, Ralph Weissleder, Hakho Lee. Nat Med 2012
409
33

Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
Marco Giallombardo, Jorge Chacártegui Borrás, Marta Castiglia, Nele Van Der Steen, Inge Mertens, Patrick Pauwels, Marc Peeters, Christian Rolfo. J Vis Exp 2016
34
33

The dilemma of low grade glioma.
I R Whittle. J Neurol Neurosurg Psychiatry 2004
43
33

Comparing the MicroRNA spectrum between serum and plasma.
Kai Wang, Yue Yuan, Ji-Hoon Cho, Sara McClarty, David Baxter, David J Galas. PLoS One 2012
415
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.